Company: SSUP
Filing Date: 2025-06-24
Form Type: 8-K
Source: 0001193125-25-145782
Chunk: 0

Company: SUPERIOR INDUSTRIES INTERNATIONAL INC
Filing Date: 2025-06-24
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01.      Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.  

On June 17, 2025, Superior Industries International, Inc. (“ Superior” or the “ Company”) received a written notice from the New York Stock Exchange (the “ NYSE”) that the Company no longer satisfies the continued listing compliance standards set forth under Section 802.01C of the NYSE Listed Company Manual (the “ Manual”) because the average closing price of the Company’s common stock, par value $0.01 per share (the “ Common Stock”) was less than $1.00 per share over a consecutive30-tradingday period (the “ Share Price Deficiency Notice”).

Pursuant to Section 802.01C of the Manual, the Company has a period of six months following receipt of the Share Price Deficiency Notice to regain compliance with the minimum share price requirement, with the possibility of extension at the discretion of the NYSE. In order to regain compliance, on the last trading day in any calendar month during the cure period, the Common Stock must have: (i) a closing price of at least $1.00 per share; and (ii) an average closing price of at least $1.00 per share over the 30 trading-day period ending on the last trading day of such month. Pursuant to NYSE rules, the Common Stock will continue to be listed and traded on NYSE during these periods, subject to the Company’s compliance with other NYSE continued listing requirements.

The Company’s current noncompliance with the standards described above does not affect the Company’s ongoing business operations or its reporting requirements with the U. S. Securities and Exchange Commission (the “ SEC”).

No assurance can be given that the Company will be able to regain compliance with the NYSE requirements or maintain compliance with the other continued listing requirements in the Manual. If the Common Stock ultimately were to be suspended from trading and delisted for any reason, it could have adverse consequences including, among other things, reduced trading liquidity of the Common Stock, lower demand and market price for shares of the Common Stock, adverse publicity and a reduced interest in the Company from investors, analysts and other market participants. In addition, a suspension or delisting could impair the Company’s ability to raise additional capital through the public markets and the Company’s ability to attract and retain employees by means of equity compensation.